United and Debiopharm Announce the Launch of Pamorelin®
News Dec 08, 2015
United Laboratories Inc. (Unilab) and Debiopharm International SA (Debiopharm) have announced the signature of an exclusive agreement for the distribution and commercialization of Pamorelin® 1, 3, and 6-month formulations in the Philippines, for the treatment of locally advanced and metastatic hormone-dependent prostate cancer and as adjuvant to radiotherapy in high-risk localized and locally advanced prostate cancer, and for the treatment of endometriosis (1- and 3-month formulations only).
Developed by Debiopharm, the product is manufactured in Switzerland by Debiopharm Research & Manufacturing SA and imported in the Philippines by Unilab. Pamorelin® LA will be made available primarily to urologists, oncologists and gynecologists across the Philippines.
“Our partnership with Debiopharm International SA adds more value to our mission as a pharmaceutical company that provides access to quality and affordable healthcare products and services,” says Jose Maria A. Ochave, Senior Vice President for Business Development Group of Unilab. “Our collaboration marks a significant step toward achieving a shared goal of providing options for better quality of life to more patients.”
“We are very happy to broaden the availability of our therapy for locally advanced and metastatic prostate cancer in Asia”, said Thierry Mauvernay, Co-President, Delegate of the Board of Debiopharm Group. “Prostate cancer is one of the most common cancers in men and we are keen on improving the quality of life of these patients. We are also pleased to offer a treatment option to women suffering from endometriosis.”
Sweet Spot of Activity in Immune System Key to Fighting CancerNews
Scientists have shown how stimulating a specific location on the surface of immune cells can be targeted with antibodies to help in their fight against cancer.READ MORE
Five Sub-types of the Brain Cancer Glioma IdentifiedNews
There are five distinct molecular sub-types of the brain cancer glioma, according to findings from the largest ever genetic study of its kind of the cancer.READ MORE
Comments | 0 ADD COMMENT
International Conference on Analytical and Bio Analytical Techniques
Oct 31 - Nov 01, 2018